Yoshiko Tomita

846 total citations
38 papers, 697 citations indexed

About

Yoshiko Tomita is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yoshiko Tomita has authored 38 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Yoshiko Tomita's work include Drug Transport and Resistance Mechanisms (9 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pneumonia and Respiratory Infections (3 papers). Yoshiko Tomita is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Pneumonia and Respiratory Infections (3 papers). Yoshiko Tomita collaborates with scholars based in Japan, United States and United Kingdom. Yoshiko Tomita's co-authors include Toshiya Katsura, Yuichi Sugiyama, Kazuya Maeda, R Hori, Ken‐ichi Inui, Masatoshi Eto, K. Nomoto, Hisanori Mayumi, Masato Yasuhara and Diego Morgavi and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Applied and Environmental Microbiology.

In The Last Decade

Yoshiko Tomita

35 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshiko Tomita Japan 16 218 183 107 93 92 38 697
Andrew Collett United Kingdom 20 322 1.5× 375 2.0× 153 1.4× 57 0.6× 56 0.6× 31 983
Lei Diao United States 16 173 0.8× 330 1.8× 60 0.6× 49 0.5× 96 1.0× 36 905
Anh T. Truong United States 18 314 1.4× 310 1.7× 138 1.3× 48 0.5× 106 1.2× 31 1.1k
Raj Kumar India 19 88 0.4× 322 1.8× 56 0.5× 35 0.4× 82 0.9× 63 1.2k
Richard Mauerer Germany 7 332 1.5× 256 1.4× 65 0.6× 31 0.3× 85 0.9× 11 742
Fumio Tamura Japan 9 126 0.6× 277 1.5× 42 0.4× 28 0.3× 116 1.3× 12 730
Chi Hin Cho Hong Kong 13 175 0.8× 377 2.1× 24 0.2× 106 1.1× 119 1.3× 17 765
Michiyuki Kato Japan 16 342 1.6× 560 3.1× 45 0.4× 234 2.5× 96 1.0× 45 1.0k
Anja Wilmes Austria 22 192 0.9× 699 3.8× 54 0.5× 63 0.7× 42 0.5× 45 1.3k
Diana Busch Germany 20 371 1.7× 141 0.8× 157 1.5× 58 0.6× 33 0.4× 28 1.1k

Countries citing papers authored by Yoshiko Tomita

Since Specialization
Citations

This map shows the geographic impact of Yoshiko Tomita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiko Tomita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiko Tomita more than expected).

Fields of papers citing papers by Yoshiko Tomita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiko Tomita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiko Tomita. The network helps show where Yoshiko Tomita may publish in the future.

Co-authorship network of co-authors of Yoshiko Tomita

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiko Tomita. A scholar is included among the top collaborators of Yoshiko Tomita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiko Tomita. Yoshiko Tomita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tomita, Yoshiko, et al.. (2022). Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy. Journal of Clinical Psychopharmacology. 42(3). 260–269. 6 indexed citations
3.
Tomita, Yoshiko, et al.. (2021). Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes. Clinical and Translational Science. 15(4). 1014–1026. 15 indexed citations
5.
Tomita, Yoshiko, Kazuya Maeda, & Yuichi Sugiyama. (2012). Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG-CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism. Clinical Pharmacology & Therapeutics. 94(1). 37–51. 71 indexed citations
6.
Tomita, Yoshiko, et al.. (2011). Optimal Dosage Regimen of Meropenem for Pediatric Patients Based on Pharmacokinetic/Pharmacodynamic Considerations. Drug Metabolism and Pharmacokinetics. 26(5). 523–531. 25 indexed citations
7.
Teramoto, Takahide, Toshiyuki Fukao, Yoshiko Tomita, et al.. (2006). Pharmacokinetics of Beclomethasone Dipropionate in an Hydrofluoroalkane-134a Propellant System in Japanese Children with Bronchial Asthma. Allergology International. 55(3). 317–320. 1 indexed citations
8.
Abu‐Jawdeh, Graziella M., Natalia Comella, Yoshiko Tomita, et al.. (1999). Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy.. PubMed. 79(4). 439–47. 76 indexed citations
9.
Tomita, Yoshiko, et al.. (1995). Transport of oral cephalosporins by the H+/dipeptide cotransporter and distribution of the transport activity in isolated rabbit intestinal epithelial cells.. Journal of Pharmacology and Experimental Therapeutics. 272(1). 63–69. 12 indexed citations
10.
Takano, Mikihisa, Yoshiko Tomita, Toshiya Katsura, et al.. (1994). Bestatin transport in rabbit intestinal brush-border membrane vesicles. Biochemical Pharmacology. 47(6). 1089–1090. 9 indexed citations
11.
Tomita, Yoshiko. (1994). [A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus].. PubMed. 95(7). 425–34. 1 indexed citations
12.
Morgavi, Diego, et al.. (1994). Presence in rumen bacterial and protozoal populations of enzymes capable of degrading fungal cell walls. Microbiology. 140(3). 631–636. 37 indexed citations
14.
Takano, Mikihisa, Toshiya Katsura, Yoshiko Tomita, Masato Yasuhara, & Ryohei Hori. (1993). Transport Mechanism of Choline in Rat Renal Brush-Border Membrane.. Biological and Pharmaceutical Bulletin. 16(9). 889–894. 10 indexed citations
15.
Jyonouchi, Harumi, et al.. (1993). Immunomodulating actions of nucleotides. 34(5). 5 indexed citations
16.
Hidaka, T., et al.. (1991). Generation of leukotrienes and hydroxyeicosatetraenoic acids in peritoneal macrophages of tumor-bearing mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 44(3). 185–190. 3 indexed citations
17.
Engelman, Robert W., et al.. (1990). Calorie Consumption Level Influences Development of C3H/Ou Breast Adenocarcinoma with Indifference to Calorie Source. Experimental Biology and Medicine. 193(1). 23–30. 25 indexed citations
18.
Tomita, Yoshiko, Hisanori Mayumi, Masatoshi Eto, & K. Nomoto. (1990). Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?. The Journal of Immunology. 144(2). 463–473. 64 indexed citations
19.
Matsumoto, Y, Kazuhiro Kawai, Yoshiko Tomita, & M Fujiwara. (1990). Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.. PubMed. 69(2). 215–21. 28 indexed citations
20.
Tomita, Yoshiko, et al.. (1990). Transport mechanisms of bestatin in rabbit intestinal brush-border membranes: role of H+/dipeptide cotransport system.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 859–862. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026